Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0104545012
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Pre Market | 02453851 | BARD PHARMACEUTICALS (1990) INC | BAR-MORPHINE SR | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 100 MG |
Marketed | 02184451 | BGP PHARMA ULC | KADIAN | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 100 MG |
Marketed | 02019965 | ETHYPHARM INC | M-ESLON | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 100 MG |
Cancelled Post Market | 02350920 | SANIS HEALTH INC | MORPHINE SR | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 100 MG |
Marketed | 02014319 | PURDUE PHARMA | MS CONTIN | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 100 MG |
Cancelled Post Market | 02145952 | PURDUE PHARMA | MS CONTIN SUPPOSITORIES - 100MG | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 100 MG / SUP |
Cancelled Pre Market | 02346397 | TEVA CANADA LIMITED | NTP-MORPHINE SR | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 100 MG |
Cancelled Post Market | 01988743 | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | ORAMORPH SR TABLETS 100MG | Human | No | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 100 MG / TAB |
Cancelled Post Market | 02245287 | PHARMASCIENCE INC | PMS-MORPHINE SULFATE SR 100 MG | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 100 MG |
Marketed | 02478889 | SANDOZ CANADA INCORPORATED | SANDOZ MORPHINE SR | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 100 MG |
Marketed | 02302799 | TEVA CANADA LIMITED | TEVA-MORPHINE SR | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 100 MG |
Application information
Related information
Contact us
Version 4.0.3